Dimethyl Fumarate Prevents the Development of Chronic Social Stress-Induced Hypertension in Borderline Hypertensive Rats

This study investigated the effects of chronic crowding-induced social stress and dimethyl fumarate (DMF) on borderline hypertensive rats, focusing on the transcription nuclear factor (erythroid-derived 2)-like 2 (NRF2) gene <i>Nfe2l2</i>, on the expression of selected NFR2-mediated gene...

Full description

Saved in:

Bibliographic Details
Main Authors:	Michal Kluknavsky (Author), Peter Balis (Author), Silvia Liskova (Author), Andrea Micurova (Author), Martin Skratek (Author), Jan Manka (Author), Iveta Bernatova (Author)
Format:	Book
Published:	MDPI AG, 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

(-)-Epicatechin Reduces the Blood Pressure of Young Borderline Hypertensive Rats During the Post-Treatment Period
by: Michal Kluknavsky, et al.
Published: (2020)

A Single Infusion of Polyethylene Glycol-Coated Superparamagnetic Magnetite Nanoparticles Alters Differently the Expressions of Genes Involved in Iron Metabolism in the Liver and Heart of Rats
by: Michal Kluknavsky, et al.
Published: (2023)

Mechanisms Modified by (−)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies
by: Iveta Bernatova, et al.
Published: (2021)

MLN-4760 Induces Oxidative Stress without Blood Pressure and Behavioural Alterations in SHRs: Roles of <i>Nfe2l2</i> Gene, Nitric Oxide and Hydrogen Sulfide
by: Michal Kluknavsky, et al.
Published: (2022)

Preliminary Findings on the Effect of Ultrasmall Superparamagnetic Iron Oxide Nanoparticles and Acute Stress on Selected Markers of Oxidative Stress in Normotensive and Hypertensive Rats
by: Lucia Laubertova, et al.
Published: (2022)

Therapeutic Effects of Dimethyl Fumarate on the Rat Model of Brain Ischemia
by: Maryam Owjfard, et al.
Published: (2022)

Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023)

Dimethyl fumarate for treating Papillon-Lefèvre syndrome
by: Abdullah Al-Omair, MD, et al.
Published: (2023)

Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
by: Shiri Li, et al.
Published: (2021)

Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
by: Maria Rosito, et al.
Published: (2020)

Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
by: Kaiyuan Chen, et al.
Published: (2021)

Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro
by: Takehiro Kawashiri, et al.
Published: (2018)

Novel potential pharmacological applications of dimethyl fumarate-an overview and update
by: Giorgia Bresciani, et al.
Published: (2023)

Effect of Chronic Social Stress on Endothelial Function of the Mesenteric Artery of Normotensive and Spontaneously Hypertensive Rats
by: Kaprinay B., et al.
Published: (2016)

Dimethyl Fumarate as the Peripheral Blood Inflammatory Mediators Inhibitor in Prevention of Streptozotocin-Induced Neuroinflammation in Aged Rats
by: Wrona D, et al.
Published: (2022)

Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
by: Rosés Gibert P, et al.
Published: (2022)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021)

Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
by: Stephanie Kourakis, et al.
Published: (2020)

Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate)
by: Abdulmajeed M Albadi, et al.
Published: (2023)

Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report
by: Aslı Bilgic-Temel, MD, et al.
Published: (2019)

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
by: Martina Burlando, et al.
Published: (2021)

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
by: Xiaoliang Hu, et al.
Published: (2022)

Anti-Inflammatory Effects of Dimethyl Fumarate in Microglia via an Autophagy Dependent Pathway
by: Young-Sun Lee, et al.
Published: (2021)

Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations
by: Prosperini L, et al.
Published: (2016)

Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19
by: Cara A. Timpani, et al.
Published: (2020)

A Sensitization-Free Dimethyl Fumarate Prodrug, Isosorbide Di-(Methyl Fumarate), Provides a Topical Treatment Candidate for Psoriasis
by: Krzysztof Bojanowski, et al.
Published: (2021)

Glucose-Impaired Corneal Re-Epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate
by: Giovanni Giurdanella, et al.
Published: (2021)

Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
by: Sarah A. Scuderi, et al.
Published: (2020)

Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate
by: Nicholas JA, et al.
Published: (2014)

New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
by: Paolinelli Matteo, et al.
Published: (2022)

Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise
by: Shilu Deepa Thomas, et al.
Published: (2022)

The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
by: Roberto De Masi, et al.
Published: (2021)

Cost-effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain
by: Ricardo Ginestal, et al.
Published: (2023)

Lung-Targeted Delivery of Dimethyl Fumarate Promotes the Reversal of Age-Dependent Established Lung Fibrosis
by: Kosuke Kato, et al.
Published: (2022)

Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study
by: Cédric O. Renaud, et al.
Published: (2022)

Preparation and Statistical Modeling of Solid Lipid Nanoparticles of Dimethyl Fumarate for Better Management of Multiple Sclerosis
by: Smriti Ojha, et al.
Published: (2018)

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
by: Laura Gnesotto, et al.
Published: (2023)

Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing–remitting multiple sclerosis
by: Ruggieri S, et al.
Published: (2014)

Dimethyl Fumarate Strongly Ameliorates Gray and White Matter Brain Injury and Modulates Glial Activation after Severe Hypoxia-Ischemia in Neonatal Rats
by: Jon Ander Alart, et al.
Published: (2024)

Effect of dimethyl fumarate in patients with plaque psoriasis meeting the upgrade criteria required for moderate‐to‐severe disease classification
by: Sascha Gerdes, et al.
Published: (2024)